Inflexion launches Healthcare Advisory Board

Inflexion Private Equity Partners LLP (“Inflexion”) is delighted to announce that it has launched a Healthcare Advisory Board to help shape its investment strategy and drive value across healthcare investments, both in the UK and internationally.

The Board is comprised of:

Inflexion currently has a dedicated team of 11 professionals focused on healthcare investing in the UK and across Europe. It has a number of healthcare companies in its current portfolio including Rosemont Pharmaceuticals, CNX Therapeutics, Pharmaspectra and ELCG